Showing results (81-90 of 399) with videos related to

Sort By:
Pageof 40
Seminars in Oncology|May 3, 2008
Optimizing outcomes for patients with advanced disease in chronic myelogenous leukemiaFrancis J Giles, Daniel J DeAngelo, Michele Baccarani, et al.
Plos One|October 7, 2014
A multicenter phase I/II study of obatoclax mesylate administered as a 3- or 24-hour infusion in older patients with previously untreated acute myeloid leukemiaAaron D Schimmer, Azra Raza, Thomas H Carter, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 24, 2004
A-type lamins regulate retinoblastoma protein function by promoting subnuclear localization and preventing proteasomal degradationBrett R Johnson, Ryan T Nitta, Richard L Frock, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|October 28, 2006
Impact of conditioning regimen intensity on outcome of allogeneic hematopoietic cell transplantation for advanced acute myelogenous leukemia and myelodysplastic syndromeEdwin P Alyea, Haesook T Kim, Vincent Ho, et al.
British Journal of Haematology|March 9, 2017
Self-reported sleep disturbance and survival in myelodysplastic syndromesMarlise R Luskin, Angel M Cronin, Robert L Owens, et al.
Leukemia & Lymphoma|August 11, 2011
Prevention and management of asparaginase/pegasparaginase-associated toxicities in adults and older adolescents: recommendations of an expert panelWendy Stock, Dan Douer, Daniel J DeAngelo, et al.
British Journal of Haematology|January 8, 2011
The frequency and management of asparaginase-related thrombosis in paediatric and adult patients with acute lymphoblastic leukaemia treated on Dana-Farber Cancer Institute consortium protocolsRachael F Grace, Suzanne E Dahlberg, Donna Neuberg, et al.
Leukemia Research|May 7, 2013
Predictive factors for all-trans retinoic acid-related differentiation syndrome in patients with acute promyelocytic leukemiaHoury Leblebjian, Daniel J DeAngelo, J Andrew Skirvin, et al.
Cell|October 16, 2012
Relative mitochondrial priming of myeloblasts and normal HSCs determines chemotherapeutic success in AMLThanh-Trang Vo, Jeremy Ryan, Ruben Carrasco, et al.
Blood Advances|January 24, 2025
Clinical use of measurable residual disease in adult ALL: recommendations from a panel of US expertsNicholas J Short, Ibrahim Aldoss, Daniel J DeAngelo, et al.
Pageof 40